Cancer Gene Therapy
Studies from University of Cincinnati, Department of Environmental Health Add New Findings in the Area of Cancer Gene Therapy
Published in Gene Therapy Weekly, January 20th, 2011
2011 JAN 20 -- Scientists discuss in 'The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis' new findings in Cancer Gene Therapy. According to a study from the United States, "The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the biological and toxic effects of its xenobiotic ligands. Previous cell culture studies have shown that, in addition to controlling the xenobiotic detoxification response, AHR activation leads to G0-G1 arrest, diminished capacity for DNA replication, and inhibition of cell proliferation."
"In fact, recent work from our own and from other laboratories suggests...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-01-20)
More Articles from Gene Therapy Weekly
- Gene Therapy
Data from A.E. Carnes and Colleagues Advance Knowledge in Gene Therapy - Gene Therapy
Data from P.I. Makinen et al Provide New Insights into Gene Therapy - Gene Therapy
Data on Gene Therapy Described by N. Movsesyan et al - Antisense Technology
Findings from Inner Mongolia University, College of Life Sciences Advance Knowledge in Antisense Technology - Small Interference RNAs (siRNAs)
Findings from Second Military Medical University, Institute of Immunology in Small Interference Rnas (sirnas) Reported - Gene Therapy
Findings in Gene Therapy Reported from New York University, University Cancer Institute - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
